Transparency Market Research (TMR) has
published a new report titled, ‘Transcatheter Embolization and Occlusion
Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and
Forecast, 2019–2027’. According to the report, the global transcatheter
embolization and occlusion devices market was valued at US$
2,957.4 Mn in 2018 and is projected to expand at a
CAGR of 7.8% from 2019 to 2027. In
terms of volume, the transcatheter embolization and occlusion devices were
accounted at 72,93,954 units in 2018.
Request
a Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2242
Overview
- Transcatheter embolization is a process of placing synthetic
material or medication called embolic agent into blood vessels through a
catheter to block blood flow toward a specific area of the body.
- Embolization is a highly effective way to prevent abnormal
bleeding and is minimally invasive as compared to open surgery.
Additionally, the technology is proving its efficiency in treatment while
performing complex surgeries.
- Surge in incidence of cardiovascular diseases, respiratory
disorders, and cancer are anticipated to drive demand for transcatheter
embolization and occlusion devices during the forecast period.
- North America dominated the global transcatheter embolization
and occlusion devices market in 2018 and the trend is
anticipated to continue during the forecast period. Highly structured
health care industry, increased adoption of minimally invasive surgeries,
and introduction of the Affordable Care Act in the U.S. are expected to
drive the market in North America.
- Asia Pacific is likely to be a highly lucrative market for
transcatheter embolization and occlusion devices and it is expected to
expand at a high CAGR during the forecast period
Enquiry
Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2242
High Prevalence of Obesity Drives Usage of
Transcatheter Embolization and Occlusion Devices in Treatment of Peripheral
Vascular Diseases
- Increase in obesity is leading to various disorders across the
globe. According to the WHO, more than 1.9 billion adults
were overweight in 2016. Of these over 650
million were obese. Most of the world's population lives in
countries where overweight and obesity account more deaths than underweight.
- This is likely to increase the number of treatment procedures;
consequently, propelling the global transcatheter embolization and
occlusion devices market. The embolization coils segment is likely to
account for major market share due to technologically advanced products
adopted by health care providers.
Peripheral Vascular Disease Segment Accounted for
Significant Market Share
- In terms of application, the global transcatheter embolization and
occlusion devices market has been segmented into peripheral vascular
disease, neurology, oncology, urology, and others. Peripheral vascular
disease is projected to be a highly attractive segment during the forecast
period.
- The segment is expected to continue to lead the market from 2019 to 2027 due
to increase in geriatric population, changing lifestyles leading to a high
prevalence of obesity, and rise in demand for minimally invasive
procedures. However, the oncology segment is expected to expand at a high
CAGR during the forecast period due to the rise in prevalence of cancer
across the globe.
Request
Report Methodology: https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=2242
Diagnostic Centers to be Promising Segment
- In terms of end-user, the global transcatheter embolization and
occlusion devices market has been classified into hospitals, ambulatory
surgical centers, and clinics. The hospitals segment held major share of
the global market in 2018.
- Growth of the hospitals segment can be attributed to the
availability of multiple service options & devices and tie-ups with
health care companies to enhance health care products and service
offerings. Moreover, hospitals are the preferred choice due to
availability of advanced technology and better health care services.
- The hospitals segment is expected to expand at a high CAGR,
especially in developed countries, due to increase in geriatric population
and rise in health care infrastructure and support. Additionally, surge in
demand for transcatheter embolization and occlusion devices in ambulatory
surgical centers during medical emergency is likely to drive the segment.
North America to Dominate Global Market
- In terms of region, the global transcatheter embolization and
occlusion devices market has been segmented into North America, Europe,
Asia Pacific, Latin America, and Middle East & Africa. North America
dominated the global transcatheter embolization and occlusion devices
market in 2018, followed by Europe.
- The market in the North America is driven by highly developed
health care sector, increase in awareness among health care providers
about transcatheter embolization and occlusion devices, and continuous
evolution of transcatheter embolization and occlusion devices.
- The Transcatheter Embolization and Occlusion Devices market in Asia
Pacific is anticipated to expand at a high CAGR during the forecast period
due to increase in awareness about transcatheter embolization and
occlusion devices for therapeutics. Moreover, expansion of the health care
sector in countries such as China, Japan, and India offers immense
potential in the region.
- Technological advancements and increase in rate of adoption of
transcatheter embolization and occlusion devices products are expected to
propel the market in the region during the forecast period.
Ask
References: https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=2242
Competitive Landscape
- The global transcatheter embolization and occlusion devices market
is highly fragmented in terms of number of players providing different
products. Key players in the global market include BTG plc, Boston
Scientific Corporation, Medtronic plc, Penumbra, Inc., Cook Medical,
Edwards Lifesciences Corporation, Merit Medical Systems, Johnson &
Johnson Services, Inc., Pfizer, Inc., Stryker Corporation, Terumo
Corporation, Sirtex Medical Limited, and Abbott Laboratories. Expansion
of product portfolio through mergers and acquisitions is a key strategy
followed by these players.
The global transcatheter embolization and occlusion
devices market has been segmented as follows:
Global Transcatheter Embolization and Occlusion
Devices Market, by Product
- Embolization Coils
- Coiling Assist Devices
- Embolization Particles
- Flow Diverter Devices
- Liquid Embolics
- Accessories
Global Transcatheter Embolization and Occlusion
Devices Market, by Application
- Peripheral Vascular Disease
- Neurology
- Oncology
- Urology
- Others
Global Transcatheter Embolization and Occlusion
Devices Market, by End-user
- Hospitals
- Ambulatory Surgical Centers
- Clinics
Request
For Custom Research: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2242
Global Transcatheter Embolization and Occlusion
Devices Market, by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
More Trending Reports by Transparency Market Research:
Motion Preservation Devices Market - https://www.transparencymarketresearch.com/motion-preservation-devices-market.html
Endoscope Washer Disinfector Market - https://www.transparencymarketresearch.com/endoscope-washerdisinfectors-market.html
Analytical Standards Market - https://www.transparencymarketresearch.com/analytical-standards-market.html
Biobanking Market - https://www.transparencymarketresearch.com/biobanking-market.html
Vitamin D Testing Market - https://www.transparencymarketresearch.com/vitamin-d-testing-market.html
Laboratory Gas Generators Market - https://www.transparencymarketresearch.com/laboratory-gas-generators-market.html
Critical Limb Ischemia Treatment Market - https://www.transparencymarketresearch.com/critical-limb-ischemia-treatment.html
Mice Model Technologies Market - https://www.transparencymarketresearch.com/mice-model-technologies-market.html
About Us
Transparency
Market Research, a global market research company registered at Wilmington,
Delaware, United States, provides custom research and consulting services. The
firm scrutinizes factors shaping the dynamics of demand in various
markets. The insights and perspectives on the markets evaluate
opportunities in various segments. The opportunities in the segments based on
source, application, demographics, sales channel, and end-use are analysed,
which will determine growth in the markets over the next decade.
Our
exclusive blend of quantitative forecasting and trends analysis provides
forward-looking insights for thousands of decision-makers, made possible by
experienced teams of Analysts, Researchers, and Consultants. The proprietary
data sources and various tools & techniques we use always reflect the
latest trends and information. With a broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary research
techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our
YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
No comments:
Post a Comment